title: Repression of cancer protective genes by 17beta-estradiol: ligand-dependent interaction between human Nrf2 and estrogen receptor alpha.
abstract: Repression of cancer-protective phase II enzymes may help explain why estrogen exposure leads to the development of cancer. In an earlier report we described the ability of 17beta-estradiol (E(2)) to repress phase II enzyme activity in vivo. Phase II enzymes are coordinately regulated via the presence of the antioxidant response element (ARE) in their promoter. We wanted to determine if estrogen receptors (ER) repress ARE-dependent gene expression through a mechanism that requires interaction with Nrf2, the transcription factor that regulates ARE-mediated gene transcription. E(2)-bound ERalpha, but not ERbeta, represses ARE-regulated gene expression in the presence of exogenously expressed Nrf2 as well as when the transactivation domain of Nrf2 was fused to a heterologous DNA-binding domain. Deletion of the activation function-2 (AF-2) and the ligand-binding domain of ERalpha result in a constitutive repression of Nrf2-mediated transcription. Finally, E(2)-bound ERalpha co-immunoprecipitates with Nrf2. Repression of Nrf2-mediated transcription by E(2)-bound ERalpha expands our knowledge of E(2)-regulated genes and provides a potential drug-screening target for the development of selective estrogen receptor modulators with a lower risk of causing cancer.
authors.affiliation: Department of Biochemistry, University of Missouri, Columbia, MO, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Ansell
authors.forename: S-C
authors.initials: SC
authors.lastname: Lo
authors.forename: L G
authors.initials: LG
authors.lastname: Newton
authors.forename: C
authors.initials: C
authors.lastname: Espinosa-Nicholas
authors.forename: D D
authors.initials: DD
authors.lastname: Zhang
authors.forename: J-H
authors.initials: JH
authors.lastname: Liu
authors.forename: M
authors.initials: M
authors.lastname: Hannink
authors.forename: D B
authors.initials: DB
authors.lastname: Lubahn
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000502:physiology*; D002460:Cell Line; D004958:Estradiol / Q000494:pharmacology*; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism*; D047629:Estrogen Receptor beta / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D020868:Gene Silencing; D017930:Genes, Reporter; D006801:Humans; D008024:Ligands; D051267:NF-E2-Related Factor 2 / Q000235:genetics / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism; D020218:Response Elements
chemical_list: D000975:Antioxidants; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D008024:Ligands; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D009687:Nuclear Proteins; D004958:Estradiol